Design and analysis of clinical trials for predictive medicine. (2015)
- Record Type:
- Book
- Title:
- Design and analysis of clinical trials for predictive medicine. (2015)
- Main Title:
- Design and analysis of clinical trials for predictive medicine
- Further Information:
- Note: Edited by Shigeyuki Matsui, Marc Buyse, Richard Simon.
- Editors:
- Matsui, Shigeyuki
Buyse, Marc E
Simon, Richard M, 1943- - Contents:
- INTRODUCTORY OVERVIEW; Clinical Trials for Predictive Medicine: New Paradigms and Challenges ; Richard Simon, Shigeyuki Matsui, and Marc Buyse ; ; An Industry Statistician’s Perspective on Personalized Health Care Drug Development ; Jane Fridlyand, Ru-Fang Yeh, Howard Mackey, Thomas Bengtsson, Paul Delmar, Greg Spaniolo, and Grazyna Lieberman ; ; Analytical Validation of In Vitro Diagnostic Tests ; Robert Becker, Jr. ; ; EARLY CLINICAL TRIALS USING BIOMARKERS ; Phase I Dose-Finding Designs and Their Applicability to Targeted Therapies ; Takashi Daimon, Akihiro Hirakawa, and Shigeyuki Matsui ; ; An Overview of Phase II Clinical Trial Designs with Biomarkers ; Lisa McShane and Sally Hunsberger ; ; Bayesian Adaptive Methods for Clinical Trials of Targeted Agents ; Peter Thall ; ; Outcome-Adaptive Randomization in Early Clinical Trials ; Edward Korn and Boris Freidlin ; ; Challenges of Using Predictive Biomarkers in Clinical Trials ; Sumithra Mandrekar and Daniel Sargent ; ; PHASE III RANDOMIZED CLINICAL TRIALS USING BIOMARKERS ; Comparison of Randomized Clinical Trial Designs for Targeted Agents ; Antje Hoering, Mike LeBlanc, and John Crowley ; ; Phase III All-Comers Clinical Trials with a Predictive Biomarker ; Shigeyuki Matsui, Yuki Choai, and Takahiro Nonaka ; ; Evaluation of Clinical Utility and Validation of Gene Signatures in Clinical Trials ; Stefan Michiels and Federico Rotolo ; ; ANALYSIS OF HIGH-DIMENSIONAL DATA AND GENOMIC SIGNATURE DEVELOPMENTS ; Statistical IssuesINTRODUCTORY OVERVIEW; Clinical Trials for Predictive Medicine: New Paradigms and Challenges ; Richard Simon, Shigeyuki Matsui, and Marc Buyse ; ; An Industry Statistician’s Perspective on Personalized Health Care Drug Development ; Jane Fridlyand, Ru-Fang Yeh, Howard Mackey, Thomas Bengtsson, Paul Delmar, Greg Spaniolo, and Grazyna Lieberman ; ; Analytical Validation of In Vitro Diagnostic Tests ; Robert Becker, Jr. ; ; EARLY CLINICAL TRIALS USING BIOMARKERS ; Phase I Dose-Finding Designs and Their Applicability to Targeted Therapies ; Takashi Daimon, Akihiro Hirakawa, and Shigeyuki Matsui ; ; An Overview of Phase II Clinical Trial Designs with Biomarkers ; Lisa McShane and Sally Hunsberger ; ; Bayesian Adaptive Methods for Clinical Trials of Targeted Agents ; Peter Thall ; ; Outcome-Adaptive Randomization in Early Clinical Trials ; Edward Korn and Boris Freidlin ; ; Challenges of Using Predictive Biomarkers in Clinical Trials ; Sumithra Mandrekar and Daniel Sargent ; ; PHASE III RANDOMIZED CLINICAL TRIALS USING BIOMARKERS ; Comparison of Randomized Clinical Trial Designs for Targeted Agents ; Antje Hoering, Mike LeBlanc, and John Crowley ; ; Phase III All-Comers Clinical Trials with a Predictive Biomarker ; Shigeyuki Matsui, Yuki Choai, and Takahiro Nonaka ; ; Evaluation of Clinical Utility and Validation of Gene Signatures in Clinical Trials ; Stefan Michiels and Federico Rotolo ; ; ANALYSIS OF HIGH-DIMENSIONAL DATA AND GENOMIC SIGNATURE DEVELOPMENTS ; Statistical Issues in Clinical Development and Validation of Genomic Signatures ; Shigeyuki Matsui ; ; Univariate Analysis for Gene Screening: Beyond Multiple Testing ; Hisashi Noma and Shigeyuki Matsui ; ; Statistical and Machine-Learning Methods for Class Prediction in High Dimension ; Osamu Komori and Shinto Eguchi ; ; Survival Risk Prediction Using High-Dimensional Molecular Data ; Harald Binder, Thomas Gerds, and Martin Schumacher ; ; RANDOMIZED TRIALS WITH BIOMARKER DEVELOPMENT AND VALIDATION ; Adaptive Clinical Trial Designs with Biomarker Development and Validation ; Boris Freidlin and Richard Simon ; ; Development and Validation of Continuous Genomic Signatures in Randomized Clinical Trials ; Shigeyuki Matsui ; ; EVALUATION OF SURROGATE BIOMARKERS ; Biomarker-Based Surrogate Endpoints ; Marc Buyse, Tomasz Burzykowski, Geert Molenberghs, and Ariel Alonso … (more)
- Edition:
- 1st
- Publisher Details:
- Boca Raton : Chapman & Hall/CRC
- Publication Date:
- 2015
- Extent:
- 1 online resource, illustrations (black and white)
- Subjects:
- 610.724
Clinical trials -- Statistical methods
Prognosis
Molecular diagnosis - Languages:
- English
- ISBNs:
- 9781466558168
- Related ISBNs:
- 9781466558151
- Notes:
- Note: Description based on CIP data; item not viewed.
- Access Rights:
- Legal Deposit; Only available on premises controlled by the deposit library and to one user at any one time; The Legal Deposit Libraries (Non-Print Works) Regulations (UK).
- Access Usage:
- Restricted: Printing from this resource is governed by The Legal Deposit Libraries (Non-Print Works) Regulations (UK) and UK copyright law currently in force.
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library HMNTS - ELD.DS.138263
- Ingest File:
- 02_032.xml